Company Filing History:
1 out of 47 
1 out of 1 
1 out of 1 Years Active: 2014
Title: The Innovative Contributions of Rodolfo Lavilla Grifols
Introduction
Rodolfo Lavilla Grifols is a notable inventor based in Castelldefels, Spain. He has made significant contributions to the field of cancer treatment through his innovative research and patenting efforts. His work focuses on developing compounds that can inhibit tumor cell proliferation and induce apoptosis, providing new avenues for cancer therapy.
Latest Patents
Rodolfo Lavilla Grifols holds a patent for "Fluorinated thiazoles for use in treating cancer." This patent describes compounds of formula (I) or their pharmaceutically acceptable salts, or their stereoisomers or mixtures of stereoisomers. The compounds are designed to inhibit cell proliferation of tumor cells independently of the p53 protein and may also induce apoptosis in several tumor cells. This innovation is particularly useful for the treatment of various types of cancer.
Career Highlights
Throughout his career, Rodolfo has worked with prestigious institutions such as the Universitat de Barcelona and the Fundació Privada Institut d'Investigació Biomèdica de Bellvitge. His research has contributed to advancements in biomedical science, particularly in the area of oncology.
Collaborations
Rodolfo has collaborated with esteemed colleagues, including Joan Gil Santano and Fernando Albericio Palomera. These partnerships have enhanced his research and contributed to the development of innovative cancer treatments.
Conclusion
Rodolfo Lavilla Grifols is a prominent figure in the field of cancer research, with a focus on developing effective treatments through innovative compounds. His contributions continue to impact the medical community and offer hope for cancer patients worldwide.